Bliss GVS Pharma has informed that it has enclosed the half yearly compliance certificate issued by Company Secretary in Practice as per Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended September 30, 2020.
The above information is a part of company’s filings submitted to BSE.